drugset / Trial / NCT02358369
Dose-Ranging Study of the Bimatoprost Ocular Insert
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The Bimatoprost Ocular Insert is intended to provide sustained delivery of bimatoprost to the ocular surface to lower the intraocular pressure (IOP) in patients with Open-Angle Glaucoma or Ocular Hypertension. This study evaluated the safety and efficacy of two different doses of the Bimatoprost Ocular Insert, compared to an active control arm with timolol ophthalmic solution (0.5%).
Timeline
- Start
- 2015-01-19
- Primary completion
- 2015-08-31
- Completion
- 2015-10-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | 2.2 mg | Topical |
| Subject | Bimatoprost | Other / unclassified | 13 mg | Topical |
| Comparator | Timolol | Other / unclassified | 0.5 % | Topical |